SEC Tracker
Get the app

Possible new JUNS shares

JUNSDilution

Known so far: no new shares from the prospectus covers read · shelf room about $6.7M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $6.7M, maybe lower
  • One third of float $6.7M ($20.2M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $6.7M on the S-3 of Apr 16, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $20.2M public float stated as of Jun 30, 2025, $6.7M, nothing sold off it in the last 12 months; 2 more sales off the shelf with no size read, so the room may be lower. Sources: S-3 Apr 16, 2026, effective Apr 24, 2026 · public float, as of Jun 30, 2025 · 424B5 May 21, 2026 · 424B5 Aug 24, 2026.

What could become new Jupiter Neurosciences (JUNS) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (770K shares, +66% from 464K on Aug 18, 2025, adjusted for the 1-for-75 reverse split by Aug 14, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

770K

Dec 2024 to Aug 2026: from 441K to 770K. Adjusted for the 1-for-75 reverse split by Aug 14, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.